Mucostar (Carbocisteine)

Carbocisteine, the active ingredient in Mucostar, is a mucolytic presented as a tablet for oral use. It reduces thick mucus in the respiratory tract of patients with chronic bronchitis, COPD, and other conditions requiring mucolysis.

GNH USA supplies Mucostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbocisteine acts as a mucolytic to improve clearance of airway secretions in various respiratory disorders.

Chronic bronchitis: helps clear sputum and improve breathing efficiency. COPD: reduces mucus viscosity, facilitating expectoration and easing airflow limitation. Asthma with thick mucus: assists in breaking down mucus plugs, supporting better airway patency. Other respiratory conditions requiring mucolysis: aids in mucus clearance where thick secretions impair ventilation.

Carbocisteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, usually transient. - Abdominal pain: cramping or discomfort. - Dyspepsia: indigestion or heartburn. - Headache: mild, often resolves without intervention. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Allergic reactions: swelling, hives, or difficulty breathing. - Severe gastrointestinal bleeding: uncommon but requires immediate medical attention. - Hepatic dysfunction: elevated liver enzymes in rare cases. - Hematologic abnormalities: unexplained bruising or bleeding. - Anaphylaxis: rare, life‑threatening hypersensitivity.

When using Carbocisteine, certain precautions should be observed to ensure safety.

Pregnancy: consult a healthcare professional before use; data are limited. Breastfeeding: discuss potential risks with a physician; the drug may pass into milk. Renal impairment: dose adjustment may be needed; monitor renal function. Asthma exacerbation: ensure appropriate asthma control before initiating therapy. Drug interactions: review concomitant medications for potential interactions. Store below 25°C: keep in the original pack, protect from moisture.

Carbocisteine may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antitussives containing codeine: may counteract mucolytic effect. - High‑dose aspirin: increased risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Bronchodilators: monitor for additive respiratory effects. - Antibiotics (e.g., macrolides): watch for altered gut flora leading to diarrhea. - Anticoagulants: observe for any change in bleeding tendency. - Other mucolytics: avoid concurrent use to prevent excessive mucus thinning.